Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target ; volume:19 ; number:1 ; day:26 ; month:9 ; year:2021 ; pages:1-18 ; date:12.2021
Journal of translational medicine ; 19, Heft 1 (26.9.2021), 1-18, 12.2021
- Creator
-
Capone, Emily
Iacobelli, Stefano
Sala, Gianluca
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-021-03085-w
- URN
-
urn:nbn:de:101:1-2021121621505302325777
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Capone, Emily
- Iacobelli, Stefano
- Sala, Gianluca
- SpringerLink (Online service)
Other Objects (12)
Role of galectin-3 in melanoma progression
Role of galectin-3 in melanoma progression
B4GALT1-dependent galectin-8 binding with TGF-β receptor suppresses colorectal cancer progression and metastasis
Regulation of Tumor Progression by Extracellular Galectin-3
Selection of Galectin‐Binding Ligands from Synthetic Glycopeptide Libraries
Galectin Binding to Neo-Glycoproteins: LacDiNAc Conjugated BSA as Ligand for Human Galectin-3
A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target
Galectin-3: an immune checkpoint target for musculoskeletal tumor patients
Proteogenomic Landscape of Breast Ductal Carcinoma Reveals Tumor Progression Characteristics and Therapeutic Targets
Characterisation of mRNA binding proteins as potential therapeutic targets : models and tools
Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells
Evaluation of galectin-1 as a target for therapy in neuroblastoma
Role of galectin-3 in melanoma progression
Role of galectin-3 in melanoma progression
B4GALT1-dependent galectin-8 binding with TGF-β receptor suppresses colorectal cancer progression and metastasis
Regulation of Tumor Progression by Extracellular Galectin-3
Selection of Galectin‐Binding Ligands from Synthetic Glycopeptide Libraries
Galectin Binding to Neo-Glycoproteins: LacDiNAc Conjugated BSA as Ligand for Human Galectin-3
A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target
Galectin-3: an immune checkpoint target for musculoskeletal tumor patients
Proteogenomic Landscape of Breast Ductal Carcinoma Reveals Tumor Progression Characteristics and Therapeutic Targets
Characterisation of mRNA binding proteins as potential therapeutic targets : models and tools
Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells
Evaluation of galectin-1 as a target for therapy in neuroblastoma
Role of galectin-3 in melanoma progression
Role of galectin-3 in melanoma progression
B4GALT1-dependent galectin-8 binding with TGF-β receptor suppresses colorectal cancer progression and metastasis
Regulation of Tumor Progression by Extracellular Galectin-3
Selection of Galectin‐Binding Ligands from Synthetic Glycopeptide Libraries
Galectin Binding to Neo-Glycoproteins: LacDiNAc Conjugated BSA as Ligand for Human Galectin-3
A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target
Galectin-3: an immune checkpoint target for musculoskeletal tumor patients
Proteogenomic Landscape of Breast Ductal Carcinoma Reveals Tumor Progression Characteristics and Therapeutic Targets
Characterisation of mRNA binding proteins as potential therapeutic targets : models and tools
Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells